WINTON GROUP Ltd acquired a new position in shares of LHC Group, Inc. (NASDAQ:LHCG) during the 1st quarter, according to its most recent disclosure with the SEC. The institutional investor acquired 11,742 shares of the health services provider’s stock, valued at approximately $723,000. WINTON GROUP Ltd owned approximately 0.06% of LHC Group at the end of the most recent reporting period.
Several other institutional investors and hedge funds have also recently modified their holdings of LHCG. SG Americas Securities LLC purchased a new stake in shares of LHC Group during the 1st quarter worth approximately $105,000. Envestnet Asset Management Inc. purchased a new stake in shares of LHC Group during the 1st quarter worth approximately $134,000. Cubist Systematic Strategies LLC raised its holdings in shares of LHC Group by 36.9% during the 1st quarter. Cubist Systematic Strategies LLC now owns 2,636 shares of the health services provider’s stock worth $162,000 after acquiring an additional 711 shares in the last quarter. Jefferies Group LLC purchased a new stake in shares of LHC Group during the 4th quarter worth approximately $200,000. Finally, M&T Bank Corp purchased a new stake in shares of LHC Group during the 1st quarter worth approximately $228,000. 94.26% of the stock is currently owned by institutional investors and hedge funds.
LHCG has been the topic of several recent research reports. BidaskClub raised LHC Group from a “buy” rating to a “strong-buy” rating in a report on Thursday, April 26th. Zacks Investment Research upgraded LHC Group from a “hold” rating to a “strong-buy” rating and set a $70.00 price target on the stock in a report on Tuesday, March 6th. Craig Hallum increased their price target on LHC Group from $70.00 to $80.00 and gave the company a “buy” rating in a report on Wednesday, April 4th. Jefferies Financial Group restated a “buy” rating and set a $84.00 price target on shares of LHC Group in a report on Wednesday, April 4th. Finally, ValuEngine upgraded LHC Group from a “hold” rating to a “buy” rating in a report on Saturday, June 2nd. One equities research analyst has rated the stock with a hold rating, ten have issued a buy rating and one has assigned a strong buy rating to the company’s stock. The stock has an average rating of “Buy” and an average target price of $80.22.
NASDAQ:LHCG opened at $86.38 on Tuesday. LHC Group, Inc. has a fifty-two week low of $56.76 and a fifty-two week high of $87.42. The firm has a market cap of $1.57 billion, a P/E ratio of 33.96, a P/E/G ratio of 1.35 and a beta of 0.61. The company has a debt-to-equity ratio of 0.24, a quick ratio of 1.65 and a current ratio of 1.65.
LHC Group (NASDAQ:LHCG) last released its quarterly earnings results on Wednesday, May 2nd. The health services provider reported $0.63 earnings per share for the quarter, beating the Thomson Reuters’ consensus estimate of $0.60 by $0.03. LHC Group had a return on equity of 9.29% and a net margin of 4.07%. The company had revenue of $291.10 million for the quarter, compared to analyst estimates of $295.21 million. During the same quarter in the prior year, the firm posted $0.53 EPS. LHC Group’s quarterly revenue was up 19.2% compared to the same quarter last year. sell-side analysts forecast that LHC Group, Inc. will post 3.5 EPS for the current year.
In other LHC Group news, insider Joshua L. Proffitt sold 10,556 shares of the company’s stock in a transaction on Thursday, May 17th. The stock was sold at an average price of $75.20, for a total value of $793,811.20. The sale was disclosed in a filing with the SEC, which is available at the SEC website. Also, COO Donald Dwayne Stelly sold 3,307 shares of the company’s stock in a transaction on Monday, June 11th. The shares were sold at an average price of $79.76, for a total value of $263,766.32. Following the completion of the transaction, the chief operating officer now directly owns 109,145 shares in the company, valued at approximately $8,705,405.20. The disclosure for this sale can be found here. Insiders have sold a total of 16,863 shares of company stock worth $1,274,628 in the last 90 days. 6.80% of the stock is currently owned by insiders.
About LHC Group
LHC Group, Inc, a health care provider, specializes in the post-acute continuum of care primarily for Medicare beneficiaries in the United States. The company operates through four segments: Home Health Services, Hospice Services, Community-Based Services, and Facility-Based Services. The Home Health Services segment offers home nursing services, including wound care and dressing changes, cardiac rehabilitation, infusion therapy, pain management, pharmaceutical administration, skilled observation and assessment, and patient education; medically-oriented social services; and physical, occupational, and speech therapy services.
Receive News & Ratings for LHC Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for LHC Group and related companies with MarketBeat.com's FREE daily email newsletter.